BioCryst Pharmaceuticals, Inc. (BCRX)
7.61
-0.07
(-0.91%)
USD |
NASDAQ |
Nov 13, 16:00
7.60
-0.01
(-0.13%)
After-Hours: 19:59
BioCryst Pharmaceuticals 1 Year Total Returns (Daily) : 10.29% for Nov. 13, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| November 13, 2026 | 10.29% |
| November 12, 2026 | 6.96% |
| November 11, 2026 | 5.81% |
| November 10, 2026 | 4.58% |
| November 09, 2026 | 7.62% |
| November 06, 2026 | 9.39% |
| November 05, 2026 | 6.42% |
| November 04, 2026 | 21.89% |
| November 03, 2026 | 24.93% |
| November 02, 2026 | 12.64% |
| October 30, 2026 | 16.83% |
| October 29, 2026 | 16.55% |
| October 28, 2026 | 15.61% |
| October 27, 2026 | 10.81% |
| October 26, 2026 | 9.44% |
| October 23, 2026 | 6.40% |
| October 22, 2026 | 9.89% |
| October 21, 2026 | 10.95% |
| October 20, 2026 | 14.57% |
| October 19, 2026 | 21.72% |
| October 16, 2026 | 15.92% |
| October 15, 2026 | 17.77% |
| October 14, 2026 | 25.39% |
| October 13, 2026 | 14.63% |
| October 12, 2026 | 15.79% |
| Date | Value |
|---|---|
| October 09, 2026 | 17.93% |
| October 08, 2026 | 13.87% |
| October 07, 2026 | 20.86% |
| October 06, 2026 | 13.25% |
| October 05, 2026 | 13.29% |
| October 02, 2026 | 11.46% |
| October 01, 2026 | 10.18% |
| September 30, 2026 | 9.75% |
| September 29, 2026 | 9.54% |
| September 28, 2026 | 11.01% |
| September 25, 2026 | 12.29% |
| September 24, 2026 | 9.65% |
| September 23, 2026 | 9.59% |
| September 22, 2026 | 11.00% |
| September 21, 2026 | 13.77% |
| September 18, 2026 | 9.05% |
| September 17, 2026 | 12.99% |
| September 16, 2026 | 8.77% |
| September 15, 2026 | 5.97% |
| September 14, 2026 | 4.05% |
| September 11, 2026 | 0.62% |
| September 10, 2026 | 3.50% |
| September 09, 2026 | 8.97% |
| September 08, 2026 | 10.68% |
| September 04, 2026 | 20.44% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Halozyme Therapeutics, Inc. | 40.85% |
| Neurocrine Biosciences, Inc. | 16.12% |
| Agenus, Inc. | 55.43% |
| Amgen, Inc. | 42.42% |
| Anika Therapeutics, Inc. | 32.67% |